RNA-mediated trans-activation of transcription from a viral RNA

Science

Volumn 281, Issue 5378, 1998, Pages 829-832

  Sit, Tim L ^a   Vaewhongs, Andrew A ^a   Lommel, Steven A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BASE PAIRING; GENE EXPRESSION; GENE MUTATION; MOSAIC VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RNA BINDING; RNA TRANSCRIPTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS CAPSID; VIRUS GENE;

BASE COMPOSITION; BASE SEQUENCE; DNA, COMPLEMENTARY; GENE EXPRESSION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MOSAIC VIRUSES; MUTATION; NUCLEIC ACID CONFORMATION; PROMOTER REGIONS (GENETICS); RNA, DOUBLE-STRANDED; RNA, MESSENGER; RNA, VIRAL; SEQUENCE ALIGNMENT; TRANS-ACTIVATION (GENETICS);

MIRIDAE; RED CLOVER NECROTIC MOSAIC VIRUS; RNA VIRUSES; TRIFOLIUM PRATENSE;

EID: 0032493916     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.281.5378.829     Document Type: Article

References (32)

1. L. Jaeger, Curr. Opin. Struct. Biol. 7, 324 (1997) ; B. Zhang and T. R. Cech, Nature 390, 96 (1997).
2. L. Jaeger, Curr. Opin. Struct. Biol. 7, 324 (1997) ; B. Zhang and T. R. Cech, Nature 390, 96 (1997).
3. S. A. Liebhaber, Nucleic Acids Symp. Ser. 36, 29 (1997) ; D. R. Gallie, Plant Mol. Biol. 32, 145 (1996).
4. S. A. Liebhaber, Nucleic Acids Symp. Ser. 36, 29 (1997) ; D. R. Gallie, Plant Mol. Biol. 32, 145 (1996).
5. M. D. Crespi et al., EMBO J. 13, 5099 (1994) ; C. J. Decker and R. Parker, Curr. Opin. Cell Biol. 7, 386 (1995) ; E. R. Jupe et al., Cell Growth Differ. 7, 871 (1996).
6. M. D. Crespi et al., EMBO J. 13, 5099 (1994) ; C. J. Decker and R. Parker, Curr. Opin. Cell Biol. 7, 386 (1995) ; E. R. Jupe et al., Cell Growth Differ. 7, 871 (1996).
7. M. D. Crespi et al., EMBO J. 13, 5099 (1994) ; C. J. Decker and R. Parker, Curr. Opin. Cell Biol. 7, 386 (1995) ; E. R. Jupe et al., Cell Growth Differ. 7, 871 (1996).
8. R. C. Lee, R. L. Feinbaum, V. Ambros, Cell 75, 843 (1993) ; B. Wightman, I. Ha, G. Ruvkin, ibid., p. 855.
9. R. C. Lee, R. L. Feinbaum, V. Ambros, Cell 75, 843 (1993) ; B. Wightman, I. Ha, G. Ruvkin, ibid., p. 855.
10. D. Giesman-Cookmeyer, K.-H. Kim, S. A. Lommel, in Pathogenesis and Host-Parasite Specificity in Plant Diseases: Histopathological, Biochemical, Genetic and Molecular Basis, U. S. Singh, R. P. Singh, K. Kohmoto, Eds. (Pergamon, Tarrytown, NY, 1995), vol. III, pp. 157-176.
11. M. Kozak, J. Cell Biol. 108, 229 (1989).
12. A. A. Vaewhongs and S. A. Lommel, Virology 212, 607 (1995).
13. Z. Xiong and S. A. Lommel, ibid. 182, 388 (1991).
14. W. L. Chiu et al., Curr. Biol. 6, 325 (1996).
15. + plants were repeated a minimum of three times with at least two independent constructs. All plants were maintained in a 20°C glasshouse with ambient lighting.
16. T. L. Kendall and S. A. Lommel, J. Gen. Virol. 73, 2479 (1992).
17. T. L. Sit and S. A. Lommel, unpublished data.
18. Z. Ge, C. Hiruki, K. L. Roy, J. Gen. Virol. 73, 2483 (1992) ; Z. Ge and C. Hiruki, Proc. Jpn. Acad. 69, 113 (1993).
19. Z. Ge, C. Hiruki, K. L. Roy, J. Gen. Virol. 73, 2483 (1992) ; Z. Ge and C. Hiruki, Proc. Jpn. Acad. 69, 113 (1993).
20. The wild-type GFP sequence in plasmid pGFP was cleaved with Age I, treated with Klenow fragment, and cleaved with Spe I. This GFP fragment was inserted into the infectious cDNA clone of RCNMV RNA-2 that had been cleaved with Nco I, treated with Klenow fragment, and cleaved with Xba I to produce clone R2GFP. Clone R2GΔH was produced by cleavage of R2GFP with Hpa I (within the GFP coding sequence) and Hind III (within the multiple cloning site of the plasmid) followed by insertion of the ApaL I-Hind III fragment from wild-type RCNMV RNA-2. Clone R2GΔHX was produced by cleavage of clone R2GΔH with Bgl II-Xba I followed by Klenow treatment and religation to yield a 120-nt deletion.
21. Plasmid pHST2. H. B. Scholthof, K.-B. G. Scholthof, A. O. Jackson, Annu. Rev. Phytopathol. 34, 299 (1996).
22. The RNA-2 fragment was excised from the infectious cDNA clone with ApaL I-Xba I followed by Klenow treatment and ligation into the SnaB I site of pHST2 to yield clones pHST2-RC2.3 (+) and -RC2.4 (-). The 209-nt RNA-2 insert was produced by digestion of pHST2-RC2.3 with Bgl II-Xba I followed by Klenow treatment and religation to yield clone pHST2-ΔBX.
23. RNA secondary structure was predicted with M. Zuker's mfold server at http://www.ibc.wustl.edu/ ∼zuker/rna/
24. The 5′-terminal 121-nt and 3′-terminal 91-nt regions of the 209-nt element were amplified by PCR. The products were cleaved with SnaB I-Xho I and ligated into similarly cleaved pHST2.
25. RCNMV RNA-2 inserts of 50 nt or less in pHST2 were produced by annealing of phosphorylated complementary oligonucleotides followed by ligation of the resulting double-stranded DNAs into pHST2 cleaved with SnaB I-Xho I.
26. S. K. Zavriev, C. M. Hickey, S. A. Lommel, Virology 216, 407 (1996).
27. PCR-based mutagenesis of the RNA-1 sequence was performed as by S. Li and M. F. Wilkinson [Biotechniques 23, 588 (1997)]. After amplification, the PCR product was gel-purified, cleaved with Xho I-Bgl II, and ligated into similarly cleaved R1sGFP to generate clone R1sGFP-M.
28. W. A. Miller, C. M. Brown, S. Wang, Semin. Virol. 8, 3 (1997) ; W. A. Miller, personal communication.
29. W. A. Miller, C. M. Brown, S. Wang, Semin. Virol. 8, 3 (1997) ; W. A. Miller, personal communication.
30. W. A. Miller, T. W. Dreher, T. C. Hall, Nature 313, 68 (1985) ; R. W. Siegel, S. Adkins, C. C. Kao, Proc. Natl. Acad. Sci. U.S.A. 94, 11238 (1997).
31. W. A. Miller, T. W. Dreher, T. C. Hall, Nature 313, 68 (1985) ; R. W. Siegel, S. Adkins, C. C. Kao, Proc. Natl. Acad. Sci. U.S.A. 94, 11238 (1997).
32. We thank D. Cookmeyer, T. Petty, and M. Conkling for reviewing this manuscript; J. Sheen for the sGFP and a GFP plasmid; G. Payne for a GFP plasmid; T. Okuno for the SCNMV RNA-2 cDNA clone; and H. Scholthof for the TBSV pHST2 vector. Supported in part by NSF grant MCB-9419700 to S.A.L.